Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

904
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
904
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

66
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
66
Vascular Spasm01:16

Vascular Spasm

1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibioprophylaxis in burn patients, gender affirmation surgery, and plastic surgery.

Anaesthesia, critical care & pain medicine·2026
Same author

Critical care challenges in hepatobiliary and pancreatic surgery.

Current opinion in critical care·2025
Same author

Early extubations in children intubated prior to arrival in Paediatric Burn ICU: A single center retrospective study over 1520 admissions.

Anaesthesia, critical care & pain medicine·2025
Same author

Effect of shear rate on early <i>Shewanella oneidensis</i> adhesion dynamics monitored by deep learning.

Biofilm·2024
Same author

Analgesia Nociception Index-Guided Remifentanil versus Standard Care during Propofol Anesthesia: A Randomized Controlled Trial.

Journal of clinical medicine·2022
Same author

Relationship between pre-incision Pupillary Pain Index and post-incision heart rate and pupillary diameter variation in children.

Paediatric anaesthesia·2021

Related Experiment Video

Updated: Jul 1, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

268

Changing hemostatic management in post-partum hemorrhage.

Agnès Rigouzzo1, Pierre-Antoine Froissant1, Nicolas Louvet1

  • 1Anesthesiology Intensive Care Department, Armand Trousseau Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

American Journal of Hematology
|March 7, 2024
PubMed
Summary

Rapid point-of-care viscoelastic (VET) assays quickly assess hemostasis in postpartum hemorrhage (PPH). These tests identify low fibrinogen levels, guiding timely treatment to improve patient outcomes.

More Related Videos

Integrated Compensatory Responses in a Human Model of Hemorrhage
07:57

Integrated Compensatory Responses in a Human Model of Hemorrhage

Published on: November 20, 2016

12.5K
Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.2K

Related Experiment Videos

Last Updated: Jul 1, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

268
Integrated Compensatory Responses in a Human Model of Hemorrhage
07:57

Integrated Compensatory Responses in a Human Model of Hemorrhage

Published on: November 20, 2016

12.5K
Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.2K

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Critical Care Medicine

Background:

  • Postpartum hemorrhage (PPH) requires prompt hemostasis assessment for effective management.
  • Fibrinogen levels decrease early in PPH, serving as a key indicator of severity.
  • Coagulopathy in PPH necessitates rapid diagnostic tools.

Purpose of the Study:

  • To highlight the importance of early hemostasis assessment in PPH.
  • To emphasize the role of fibrinogen as an early marker of PPH progression.
  • To discuss the utility of point-of-care viscoelastic (VET) assays in managing PPH-related coagulopathy.

Main Methods:

  • Review of current evidence on hemostasis assessment in PPH.
  • Focus on the application of point-of-care viscoelastic (VET) hemostatic assays.
  • Analysis of fibrinogen levels as a critical parameter in PPH.

Main Results:

  • VET assays provide rapid assessment of hemostatic disorders during PPH.
  • Hypofibrinogenemia is an early and reliable marker of PPH severity.
  • VET-guided fibrinogen replacement is supported by evidence.

Conclusions:

  • Early and fast hemostasis assessment is crucial for improving outcomes in PPH.
  • VET assays are valuable tools for rapid diagnosis and management of PPH coagulopathy.
  • Further research is needed to establish thresholds for other coagulation parameters.